Dexcom launched its first over-the-counter continuous glucose monitor called Stelo on Monday. Users can buy a one-month supply online for $99, or sign up for an ongoing subscription at $89 a month.

The Dexcom portfolio in the U.S. consists of the Dexcom G6 and Dexcom G7 Continuous Glucose Monitoring Systems, and now Stelo, collectively designed to address the needs of people with all types ...

Continuous glucose monitors are small, wearable devices that track blood sugar levels in real-time. While the devices are commonly prescribed to diabetics to titrate medications (e.g. insulin) to ...

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors ... In March 2024, a jury found that Dexcom’s G6 glucose monitors infringed one of three of Abbott’s ...

(Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by ...

Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...

Dexcom has become the first company to launch a generative AI-powered continuous ... individuals in monitoring their glucose levels. Oversold Healthcare Stocks to Buy The sale of CGM devices is the ...